Resolve: Methotrexate is the drug of choice after NSAIDs in rheumatoid arthritis
- 1 October 1990
- journal article
- Published by Elsevier in Seminars in Arthritis and Rheumatism
- Vol. 20 (2) , 76-80
- https://doi.org/10.1016/0049-0172(90)90020-g
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- The effect of folic acid supplementation on the toxicity of low‐dose methotrexate in patients with rheumatoid arthritisArthritis & Rheumatism, 1990
- Combination methotrexate and sulfasalazine in the management of rheumatoid arthritis: case observationsArthritis & Rheumatism, 1989
- Toxicity and serum levels of methotrexate in children with juvenile rheumatoid arthritisArthritis & Rheumatism, 1989
- Toxicity of methotrexate compared with azathioprine in the treatment of rheumatoid arthritis. A case-control study of 131 patientsArchives of internal medicine (1960), 1989
- A long‐term prospective study of the use of methotrexate in rheumatoid arthritisArthritis & Rheumatism, 1988
- Methotrexate Therapy in Rheumatoid Arthritis Current StatusDrugs, 1986
- The safety and efficacy of the use of methotrexate in long‐term therapy for rheumatoid arthritisArthritis & Rheumatism, 1986
- Impact of specific therapy upon rheumatoid arthritisArthritis & Rheumatism, 1986
- Comparison of low‐dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A Controlled Clinical TrialArthritis & Rheumatism, 1985
- Efficacy of Low-Dose Methotrexate in Rheumatoid ArthritisNew England Journal of Medicine, 1985